Report No.: NCT06976853
N Engl J Med 380(24):22952306 Kristensen SL, Rrth R, Jhund PS, Docherty KF, Sattar N, Preiss D et al (2019) Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
Journal of Orthopedic Research
The researchers concluded that defense mechanisms against reactive oxygen species are impaired in RA. To me, this sounds like a strong reason for anyone with RA to add active glutathione to their daily regimen
The 25% Boost A major study found that NAD+ supplementation increased insulin sensitivity in skeletal muscle by 25% in prediabetic women
If youre using semaglutide for type 2 diabetes, keep a closer eye on your blood sugar levels to make sure they stay in range